TCL Archive Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum January 8, 1993
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014